• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

AcroCyte Therapeutics Inc

Wednesday, June 05, 2024
Start-Up Stadium Session
Tools/Drug Development Support Tech
Company Description: AcroCyte Therapeutics is a cell-based precision medicine company. Our current focus lies in utilizing our core technology R3CE—rapid, reproducible, rare cell expansion— to assist clinical treatment and scientific research. R3CE is a robust cell proliferation and expansion platform that can enable 3D cell culture from any specimen within 2 weeks, even when the cells are extremely rare. We are a driven team of scientists, industry leaders, and entrepreneurs deeply committed to integrating 3D cell culture and medicine to drive changes in precision medicine and, in turn, save lives.​ Our team has over twenty years of experience in biomaterials, cancer oncology, liquid biopsy, and stem cell research. Our leaders consist of Silicon Valley entrepreneurs, industry leaders, and experienced scientists and engineers in biomedical and materials science.​

AcroCyte Therapeutics Inc
Company Website: https://www.acrocyte.com/

Company HQ City

New Taipei City

Company HQ State

Taiwan

Company HQ Country

Taiwan

CEO/Top Company Official

CEO - Ying Chih, Chang
Primary Speaker
Ying Chih Chang, PhD
Chief Executive Officer
AcroCyte Therapeutics Inc
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS